A San Diego biotechnology company has been refused a trademark registration for ‘Sequencing by Binding’ on the grounds that it is too descriptive. Omniome, which develops DNA sequencing tools, filed for the mark in 2017 but had its application refused by an examining attorney at the US Patent and Trademark Office (USPTO). In a precedential decision, issued on Monday, January 6, the USPTO’s Trademark Trial and Appeal Board (TTAB) upheld the original decision, concluding that ‘Sequencing by Binding’ was descriptive of the claimed goods and services.
米国商標実務 Section 2(e)(4) 姓であることを理由とする拒絶 (merely a surname)
Section 2(e)(4) Refusalとは 米国での商標登録を図る場合に、最も良くないパターンは既に競合する商標が存在しているケースですが、競合するような他人の商標がない場合でも識別力がない商標は拒絶されることが …
